COSMO FIRST LIMITED

rs,

CFL/SEC/2022-23/MAY/05 The Manager (Listing) Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Scrip Code: 508814 EljS COSMO FILMS WSSI Engineered to Enhance May 10,

70%

ls and a digital first, D2C Petcare business  Speciality Films:  Expanding Speciality portfolio (70% revenue; 18% annual growth in last 3 years). Target 80%+ revenue from Speciality by 2023 end  R&

18%

tal first, D2C Petcare business  Speciality Films:  Expanding Speciality portfolio (70% revenue; 18% annual growth in last 3 years). Target 80%+ revenue from Speciality by 2023 end  R&D & Sustainab

80%

ty Films:  Expanding Speciality portfolio (70% revenue; 18% annual growth in last 3 years). Target 80%+ revenue from Speciality by 2023 end  R&D & Sustainability focus (30+ highly qualified polymer/c

20%

mer/chemical scientists; Further expanding)  Six current patents & another seven are in pipeline  20% growth targeted from BOPET line (from FY22-23)  29% ROCE and 39% ROE – March 2022  Strong financi

29%

rent patents & another seven are in pipeline  20% growth targeted from BOPET line (from FY22-23)  29% ROCE and 39% ROE – March 2022  Strong financials (net debt/EBITDA at 0.5 times, net debt/equity at

39%

& another seven are in pipeline  20% growth targeted from BOPET line (from FY22-23)  29% ROCE and 39% ROE – March 2022  Strong financials (net debt/EBITDA at 0.5 times, net debt/equity at 0.25 times)

75%

ed to AA- with stable outlook by CRISIL  Speciality Chemicals:  Masterbatch plant (1st line with 75% captive consumption & 25% outside sale). Expansion expected in FY23.  Speciality Textile Chemicals

25%

ook by CRISIL  Speciality Chemicals:  Masterbatch plant (1st line with 75% captive consumption & 25% outside sale). Expansion expected in FY23.  Speciality Textile Chemicals – scale up in coming year

30%

Labels – under commissioning  Target 25%+ ROCE business  Petcare:  Untapped Industry growing @ 30%+  D2C Digital first Omni-channel presence in Products & Services  ESG & Corporate Governance – E

1%

alty Films …. Target 80%+ Revenue  Grow specialty portfolio from 70% to 80%+ by 2023 end  Each 1% shift in specialty adds EBITDA between Rs 4 to 5 crores  Complimentary growth in Specialized BOPE

Rs 4

specialty portfolio from 70% to 80%+ by 2023 end  Each 1% shift in specialty adds EBITDA between Rs 4 to 5 crores  Complimentary growth in Specialized BOPET Line (Shrink labels, Heat reduction films a

“Capex Project 1 2 3 Specialized BOPET Line with value add assets BOPP Line (world's largest line) CPP film Line Total”

“Estimated Capex (INR Crs) 400 350 140 890 Annual Capacity (MT) Estimated Commercial Production by 30,000 67,000 25,000 Q2, FY23 FY 2024-25 FY 2024-25  Specialized Chemicals (scaling up planned during FY23 for capex done in FY22)  D2C Pet Care businesses (15-20 nos of experience centers and enhanced online business during FY23) 21 What Investors may expect?”

“ Flexible Packaging Business: Transformation into primarily specialty films company with consistent 20%+ ROCE  Specialty Chemicals: 20% revenue with 25%+ ROCE in about 5 years  Petcare: Build and demerge the business vertical in medium term to drive shareholders valuation  Going forward B2B segment (speciality films, packaging films, specialized BOPET line, speciality chemicals) and B2C segments (D2C Pet Care and selective Speciality chemicals) will drive growth.”

Films Business

1

Other Businesses

1

Films Business

S. No. Capex Project 1 2 3 Specialized BOPET Line with value add assets BOPP Line (world's largest line) CPP film Line Total

Other Businesses

Estimated Capex (INR Crs) 400 350 140 890 Annual Capacity (MT) Estimated Commercial Production by 30,000 67,000 25,000 Q2, FY23 FY 2024-25 FY 2024-25  Specialized Chemicals (scaling up planned during FY23 for capex done in FY22)  D2C Pet Care businesses (15-20 nos of experience centers and enhanced online business during FY23) 21 What Investors may expect?  Flexible Packaging Business: Transformation into primarily specialty films company with consistent 20%+ ROCE  Specialty Chemicals: 20% revenue with 25%+ ROCE in about 5 years  Petcare: Build and demerge the business vertical in medium term to drive shareholders valuation  Going forward B2B segment (speciality films, packaging films, specialized BOPET line, speciality chemicals) and B2C segments (D2C Pet Care and selective Speciality chemicals) will drive growth. 22 Annexure: Company Overview 23 Company Overview Strong History & Leading Position Global Leader in Thermal Lam Films  Established in 1981, Cosmo Films Ltd.is the pi